Medical Predictive Science Corp, based in Charlottesville, VA, is a leading provider of innovative monitoring solutions for premature babies in neonatal intensive care units (NICUs). Their flagship product, HeRO, is a groundbreaking technology that detects subtle irregularities in heart rate variability, providing early warnings of patient distress and potential life-threatening conditions such as sepsis, NEC, UTI, meningitis, respiratory decompensation, brain pathology, and even death. Backed by extensive scientific research and the largest ever randomized control trial in neonatology, HeRO has been proven to significantly improve survival rates and reduce mortality in NICU patients, offering families the opportunity to bring their babies home sooner and safer.
Generated from the website